SCHEMBL24512636

SCHEMBL24512636

CON(C)C(=O)c1cccc(Nc2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHOA P61586 1/20 0.48
RAB9A P51151 3/20 0.47
CDC25B P30305 2/20 0.46
SIRT2 Q8IXJ6 1/20 0.45
MAPK13 O15264 1/20 0.45
MAPK12 P53778 1/20 0.45
MAPK11 Q15759 1/20 0.45
MAPK14 Q16539 1/20 0.45
AKR1C3 P42330 3/20 0.44
AKR1C2 P52895 3/20 0.44
MAPT P10636 2/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 1/20 0.44
AR P10275 1/20 0.44
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15281239 0.82 KMT2A (0.50) LMNAMEN1KMT2A
SCHEMBL691626 0.80 EGFR (0.57) RAB9AMAPTLMNAMEN1KMT2A
SCHEMBL12518620 0.80 EGFR (0.65) MAPK12MAPK1
SCHEMBL28777 0.80 MLYCD (0.54) RAB9ALMNAMEN1KMT2AALDH1A1
SCHEMBL6492606 0.80 ATM (0.60) RAB9AMAPTLMNAMAPK1HSD17B10
SCHEMBL772236 0.80 KMO (0.53) MAPTLMNAMEN1KMT2A
SCHEMBL1745412 0.79 RAB9A (0.71) RHOARAB9AAKR1C3AKR1C2MAPT
Hydrochloric Acid SCHEMBL7476159 0.78 MLYCD (0.53) RAB9ALMNAKMT2AALDH1A1NPC1
SCHEMBL2424190 0.78 TSHR (0.50) RAB9AMAPTLMNAMEN1KMT2A
SCHEMBL12359019 0.77 L3MBTL1 (0.55) RAB9AMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE PTDSS1, PTDSS2, SMPD1 RHOA 1998/4885RAB9A 685/4885CDC25B 207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.